Portfolio Holdings Detail for ISIN IE00BF4RFH31

Stock Name / Fund	iShares MSCI World Small Cap UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares III Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300PZLRJB7M8H1057
ETF Ticker	WSML(USD) LSE
ETF Ticker	WLDS(GBP) LSE
ETF Ticker	IUSN(EUR) F
ETF Ticker	IUSN.DE(EUR) CXE
ETF Ticker	WLDS.LS(GBP) CXE
ETF Ticker	WSML.LS(USD) CXE
ETF Ticker	WSML.L(GBP) LSE
ETF Ticker	WLDS.L(GBP) LSE

Holdings detail for MIRM

Show aggregate MIRM holdings

News associated with MIRM

Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $74.44

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has been assigned a consensus recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price […] - 2025-09-19 02:26:46

Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Buy Rating by Wall Street Zen

Wall Street Zen lowered shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a strong-buy rating to a buy rating in a research note released on Monday morning. Other analysts have also recently issued research reports about the stock. Raymond James Financial reissued a “strong-buy” rating on shares of Mirum Pharmaceuticals in a research note […] - 2025-08-26 03:03:11

Wall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Strong-Buy

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Sunday. A number of other equities analysts also recently weighed in on the stock. JMP Securities set a $81.00 target price […] - 2025-08-19 02:58:52

Deutsche Bank AG Buys 71,421 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Deutsche Bank AG grew its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 42.2% during the first quarter, Holdings Channel reports. The firm owned 240,744 shares of the company’s stock after purchasing an additional 71,421 shares during the period. Deutsche Bank AG’s holdings in Mirum Pharmaceuticals were worth $10,846,000 as of its most […] - 2025-08-15 05:22:53

Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. Several other research analysts have also commented on the stock. HC Wainwright raised their price objective on shares of Mirum Pharmaceuticals from $73.00 to $80.00 and gave […] - 2025-08-12 04:48:59

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 9.1% on Analyst Upgrade

Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) were up 9.1% during trading on Monday after Wall Street Zen upgraded the stock from a hold rating to a buy rating. The stock traded as high as $65.31 and last traded at $65.41. Approximately 671,423 shares traded hands during mid-day trading, an increase of […] - 2025-08-12 02:18:51

Zurcher Kantonalbank Zurich Cantonalbank Boosts Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 3.8% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 10,998 shares of the company’s stock after purchasing an additional 398 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Mirum Pharmaceuticals were worth $495,000 […] - 2025-08-08 04:48:50

Cwm LLC Boosts Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Cwm LLC boosted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 259.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 593 shares of the company’s stock after buying an additional 428 shares during the quarter. Cwm LLC’s holdings in Mirum Pharmaceuticals were worth $27,000 at the end of the most […] - 2025-08-06 04:24:52

Bank of New York Mellon Corp Buys 122,402 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Bank of New York Mellon Corp boosted its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 98.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 246,730 shares of the company’s stock after purchasing an additional 122,402 shares during the […] - 2025-07-21 04:26:48

Allspring Global Investments Holdings LLC Sells 1,195 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Allspring Global Investments Holdings LLC cut its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 12.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,786 shares of the company’s stock after selling 1,195 shares during the period. Allspring […] - 2025-07-11 04:36:57

KBC Group NV Makes New $89,000 Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

KBC Group NV acquired a new position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,967 shares of the company’s stock, valued at approximately $89,000. Other hedge funds have also added to or […] - 2025-07-08 04:42:53

Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen downgraded shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) from a buy rating to a hold rating in a research note published on Sunday morning. MIRM has been the topic of a number of other reports. HC Wainwright reiterated a “buy” rating and set a $73.00 price objective on shares of Mirum […] - 2025-07-07 03:22:59

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $60.73 Consensus Target Price from Analysts

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has earned a consensus recommendation of “Buy” from the twelve ratings firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-06-11 02:22:45

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 16.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,888 shares of the company’s stock after acquiring an additional […] - 2025-06-06 04:42:48

ProShare Advisors LLC Grows Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

ProShare Advisors LLC grew its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 31.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,457 shares of the company’s stock after acquiring an additional 3,227 shares during […] - 2025-05-26 06:09:07

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.01 Million Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lowered its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 24,327 shares of the company’s stock after selling 498 shares during the quarter. MIRAE […] - 2025-05-26 04:38:55

Nuveen Asset Management LLC Has $29.86 Million Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Nuveen Asset Management LLC boosted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 46.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 722,155 shares of the company’s stock after buying an additional 229,746 shares during the quarter. Nuveen Asset Management LLC’s holdings in Mirum Pharmaceuticals were worth $29,861,000 as of […] - 2025-05-22 06:38:53

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Bought by Millennium Management LLC

Millennium Management LLC grew its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 15.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 526,974 shares of the company’s stock after acquiring an additional 71,410 shares during the quarter. Millennium Management LLC owned about 1.10% […] - 2025-05-21 05:46:51

HC Wainwright Reiterates Buy Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Monday, Marketbeat.com reports. They currently have a $73.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 61.01% from the company’s current price. […] - 2025-05-21 03:03:17

Comerica Bank Decreases Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Comerica Bank lessened its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 76.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 617 shares of the company’s stock after selling 1,971 shares during the period. Comerica Bank’s […] - 2025-05-20 04:28:52

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) PT at $58.20

Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given an average recommendation of “Buy” by the eleven ratings firms that are covering the stock, Marketbeat reports. Ten research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […] - 2025-04-22 02:34:59

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $58.20 Consensus Target Price from Analysts

Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have earned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, MarketBeat reports. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price […] - 2025-03-28 03:34:46

AlphaQuest LLC Grows Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

AlphaQuest LLC increased its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 969.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,829 shares of the company’s stock after acquiring an additional 1,658 shares during the quarter. AlphaQuest LLC’s holdings in […] - 2025-03-20 06:04:50

Bank of New York Mellon Corp Has $5.14 Million Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Bank of New York Mellon Corp grew its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 8.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 124,328 shares of the company’s stock after acquiring an additional 9,629 shares during the period. Bank of New York Mellon Corp’s holdings in Mirum Pharmaceuticals were […] - 2025-03-18 05:09:03

Empowered Funds LLC Invests $1.38 Million in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Empowered Funds LLC acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 33,266 shares of the company’s stock, valued at approximately $1,376,000. A number of other large investors […] - 2025-02-17 06:16:48

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $57.10

Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have received a consensus rating of “Buy” from the eleven ratings firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-02-06 04:24:49

iShares MSCI World Small Cap UCITS ETF USD (Acc) MIRM holdings

Date	Number of MIRM Shares Held	Base Market Value of MIRM Shares	Local Market Value of MIRM Shares	Change in MIRM Shares Held	Change in MIRM Base Value	Current Price per MIRM Share Held	Previous Price per MIRM Share Held
2025-10-15 (Wednesday)	27,433	USD 2,090,120	USD 2,090,120
2025-10-10 (Friday)	27,268	USD 1,982,656	USD 1,982,656
2025-10-08 (Wednesday)	27,268	USD 1,986,474	USD 1,986,474
2025-10-07 (Tuesday)	27,268	USD 2,010,742	USD 2,010,742	110	USD 40,972	USD 73.74	USD 72.53
2025-10-06 (Monday)	27,158	USD 1,969,770	USD 1,969,770	0	USD -11,406	USD 72.53	USD 72.95
2025-10-03 (Friday)	27,158	USD 1,981,176	USD 1,981,176	0	USD 32,589	USD 72.95	USD 71.75
2025-10-02 (Thursday)	27,158	USD 1,948,587	USD 1,948,587	0	USD -33,947	USD 71.75	USD 73
2025-10-01 (Wednesday)	27,158	USD 1,982,534	USD 1,982,534	0	USD -8,419	USD 73	USD 73.31

Share Trades of MIRM by Blackrock for IE00BF4RFH31

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-07	BUY	110			73.740*		47.05
2025-09-08	SELL	-220			77.390*		45.78 Profit of 10,072 on sale
2025-08-15	BUY	110			67.930*		45.66
2025-08-07	BUY	336			59.820*		45.48
2025-07-29	BUY	112			51.170*		45.26
2025-07-14	BUY	224			53.280*		44.96
2025-06-30	BUY	224			50.890*		44.68
2025-06-25	BUY	336			50.130*		44.57
2025-06-20	SELL	-56			50.340*		44.45 Profit of 2,489 on sale
2025-06-12	SELL	-448			49.020*		44.23 Profit of 19,813 on sale
2025-06-02	BUY	171			45.970*		44.10
2025-05-28	BUY	114			43.730*		44.10
2025-05-14	BUY	56			44.390*		44.07
2025-05-13	BUY	112			45.270*		44.06
2025-05-07	BUY	168			41.220*		44.06
2025-04-28	BUY	56			41.310*		44.14
2025-04-16	BUY	741			38.750*		44.48
2025-04-14	BUY	112			39.590*		44.58
2025-04-08	SELL	-112			39.320*		44.76 Profit of 5,013 on sale
2025-04-04	SELL	-114			42.030*		44.82 Profit of 5,110 on sale
2025-03-28	BUY	560			45.990*		44.81
2025-03-12	SELL	-114			45.030*		44.65 Profit of 5,090 on sale
2025-03-04	SELL	-112			45.220*		44.69 Profit of 5,005 on sale
2025-02-26	SELL	-224			50.520*		44.53 Profit of 9,974 on sale
2025-02-13	BUY	57			50.700*		43.62
2025-02-12	BUY	228			50.720*		43.52
2025-01-27	BUY	57			48.480*		42.16
2025-01-23	BUY	57			48.650*		41.93
2024-12-09	BUY	2,052			43.310*		41.67
2024-12-04	BUY	114			45.470*		41.46
2024-12-03	BUY	171			45.585*		41.37
2024-11-19	BUY	342			42.090*		40.09
2024-11-18	BUY	114			41.420*		40.05
2024-11-12	BUY	228			42.280*		39.98
2024-11-11	BUY	57			41.610*		39.86
2024-11-11	BUY	57			41.610*		39.86
2024-11-07	BUY	285			41.080*		39.59
2024-11-07	BUY	285			41.080*		39.59
2024-10-23	BUY	114			38.420*		39.57
2024-10-23	BUY	114			38.420*		39.57

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MIRM

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer